Literature DB >> 9604056

Implementation of an osteoporosis research program with a mobile dual-energy X-ray absorptiometry unit: the Montana/Wyoming experience.

U Ulrich1, M Browning, E V Gaffney, K H Schöter, C H Chesnut.   

Abstract

To expedite recruitment, and subject participation, for a large clinical osteoporosis therapy trial utilizing the bisphosphonate ibandronate, an integrated network of 13 satellite clinical sites was developed, linked by a mobile clinic vehicle transporting a dual-energy X-ray absorptiometry (DXA) unit. A predominantly rural area of the United States (Montana, northern Wyoming) was accessed for the project, due to the large pool of potential subjects living in this area who were not yet involved in osteoporosis clinical studies. The results of the project to date (through 10 months) confirm the feasibility of such a study design, with 1774 subjects screened by DXA for the study, and 280 (15.8%) accepted. The mobile DXA unit has functioned according to specifications for a stationary DXA machine, with the stability of spine phantom measurements over 10 months assessed as a coefficient of variation of 0.46%. The success of the project validates the concept of performing clinical osteoporosis therapy trials in previously underutilized rural community settings, facilitated by a satellite site network and mobile clinic.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9604056     DOI: 10.1007/bf02652566

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  14 in total

1.  Enhanced precision with dual-energy X-ray absorptiometry.

Authors:  R Mazess; C H Chesnut; M McClung; H Genant
Journal:  Calcif Tissue Int       Date:  1992-07       Impact factor: 4.333

2.  Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.

Authors:  W Swaddiwudhipong; C Chaovakiratipong; P Nguntra; P Mahasakpan; P Lerdlukanavonge; S Koonchote
Journal:  Int J Epidemiol       Date:  1995-06       Impact factor: 7.196

3.  A preliminary evaluation of the lunar expert-XL for bone densitometry and vertebral morphometry.

Authors:  T Lang; M Takada; R Gee; C Wu; J Li; C Hayashi-Clark; S Schoen; V March; H K Genant
Journal:  J Bone Miner Res       Date:  1997-01       Impact factor: 6.741

Review 4.  Involutional osteoporosis.

Authors:  B L Riggs; L J Melton
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

Review 5.  The evaluation of mobile screening for diabetic retinopathy.

Authors:  C J Thompson; G P Leese
Journal:  Scott Med J       Date:  1995-02       Impact factor: 0.729

6.  Precision of dual X-ray absorptiometry and peripheral computed tomography using mobile densitometry units.

Authors:  M Wapniarz; R Lehmann; O Randerath; S Baedeker; W John; K Klein; B Allolio
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

7.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Authors:  U A Liberman; S R Weiss; J Bröll; H W Minne; H Quan; N H Bell; J Rodriguez-Portales; R W Downs; J Dequeker; M Favus
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

Review 8.  Osteoporosis: screening, prevention, and management.

Authors:  M Notelovitz
Journal:  Fertil Steril       Date:  1993-04       Impact factor: 7.329

9.  Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial.

Authors:  C Y Pak; K Sakhaee; B Adams-Huet; V Piziak; R D Peterson; J R Poindexter
Journal:  Ann Intern Med       Date:  1995-09-15       Impact factor: 25.391

10.  A prospective cohort study investigating psychosocial predictors of attendance at a mobile breast screening service.

Authors:  D Turnbull; L Irwig; J M Simpson; N Donnelly; P Mock
Journal:  Aust J Public Health       Date:  1995-04
View more
  1 in total

1.  A systematic review of methods used to conduct decentralised clinical trials.

Authors:  Amy Rogers; Giorgia De Paoli; Selvarani Subbarayan; Rachel Copland; Kate Harwood; Joanne Coyle; Lyn Mitchell; Thomas M MacDonald; Isla S Mackenzie
Journal:  Br J Clin Pharmacol       Date:  2022-01-27       Impact factor: 3.716

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.